ONdrugDelivery

ONdrugDelivery no longer posts updates here as of December 2025. It's all still going on over on our webpage or, for social posts, LinkedIn.

[ONdrugDelivery @ONdrugDelivery]

As of December 2025, ONdrugDelivery no longer posts updates here on X. It's all still going on over on our webpage or, for social posts, LinkedIn.
https://t.co/IP4EIpP5TX

[SHL Medical @shl_medical]

In ONdrugDelivery July, experts from SHL Medical's subgroups, SHL Advantec and SHL Medical Assembly and Services, explore how flexible automation and final assembly enable scalable manufacturing for cartridge-based autoinjectors.

👉 Read the full article: https://t.co/XJDSt4p6Bl

[ONdrugDelivery @ONdrugDelivery]

Published online: "ENHANCING DRUG DELIVERY WITH INNOVATIVE SOFT MIST INHALER TECHNOLOGY". Read the full ONdrugDelivery article 👉 https://t.co/KgvifuKx2B

"Dr Nicolas Buchmann and Bernhard Müllinger discuss the capabilities of soft-mist inhalers in terms of usability for patients, sustainability, compatibility with biologics and cost-effective delivery, showcasing these advantages in Resyca’s Pre-Filled Syringe Inhaler (PFSI)."

[ONdrugDelivery @ONdrugDelivery]

Published online: "NAVIGATING THE REGULATORY PATHWAY FOR NEXT-GENERATION NEBULISERS IN COMBINATION WITH BIOLOGICS". Read the full ONdrugDelivery article 👉 https://t.co/I7I7E9tEZx

"Edgar Hernan Cuevas Brun of HCMed discusses the role of nebulisers in delivering larger doses of fragile biologics, delving into the global regulatory landscape that must be understood in order to deliver these drugs on the market."

[ONdrugDelivery @ONdrugDelivery]

Published online: "ORBITAL: A NOVEL HIGH-PAYLOAD, MULTI-BREATH DPI POISED FOR CLINICAL ADVANCEMENT". Read the full ONdrugDelivery article 👉 https://t.co/FtoJisYVk9

"David Farrow, Jonathan Mulpas and Solange Le Nuz discuss the patient-centric and data-driven development of Aptar Pharma’s Orbital dry powder inhaler platform, tracing its evolution from an initial concept to a clinically-ready device."

[ONdrugDelivery @ONdrugDelivery]

Published online: "FACILITY SPOTLIGHT: UK-BASED CAPABILITIES IN INHALED AND NASAL DRUG-DEVICE PRODUCT DEVELOPMENT". Read the full ONdrugDelivery article 👉 https://t.co/dYQlsS13bE

"Ross Errington introduces Bespak’s Holmes Chapel (UK) site, which is equipped to support device development programmes from early-stage formulation to large-scale manufacture."

[ONdrugDelivery @ONdrugDelivery]

Published online: "ADVANCING ELASTOMER SEAL SOLUTIONS FOR THE PRESSURISED METERED DOSE INHALER MARKET". Read the full ONdrugDelivery article 👉 https://t.co/0PCBqMn94F

"Nathan Sowder discusses the role and history of Parker‘s O-Ring & Engineered Seals Division in providing advanced elastomer seals and components to the drug delivery industry, with a particular emphasis on pressurised metered dose inhalers."

[ONdrugDelivery @ONdrugDelivery]

Published online: "Interview: Integrating Phillips Medisize and Vectura’s Operations". Read the full ONdrugDelivery article 👉 https://t.co/TZYIHpnlp6

"In this interview, Charlie Schumacher and Sandy Munro discuss Phillips Medisize’s progress on its integration of Vectura, covering aspects such as cultural alignment, technical innovation and the evolving role of CDMOs in the inhalation landscape."

[ONdrugDelivery @ONdrugDelivery]

Published online: "FAST-TO-MARKET DEVELOPMENT OF A NOVEL NASAL SPRAY WITH SIMULTANEOUS ENGINEERING". Read the full ONdrugDelivery article 👉 https://t.co/0tmZUccd6q

"Matthias Müller of Contexo details how a close collaboration between Contexo and a pharmaceutical manufacturer led to the rapid development of a novel nasal spray product, taking the project from prototyping to market within 14 months, shaving 10 months off the anticipated launch date."

[ONdrugDelivery @ONdrugDelivery]

Published online: "CLEARING THE AIR(WAY): DEBUNKING THREE COMMON MYTHS ABOUT INHALED DRUG DELIVERY". Read the full ONdrugDelivery article 👉 https://t.co/7i5HxAJuHD

"Dr Keat Theng Chow and Susana Ecenarro of Roquette explore three myths surrounding inhalation as a route of administration, clearing the way for a deeper understanding of one of pharma’s most exciting areas for innovation."

[ONdrugDelivery @ONdrugDelivery]

Published online: "DELIVERING AND MAINTAINING OPTIMAL DPI PERFORMANCE". Read the full ONdrugDelivery article 👉 https://t.co/o9VbKWlPJv

"Chris Gilmor of Sanner Group considers the issues affecting dry powder inhalers and explains how formulators use a range of techniques to ensure dose dispersion and API detachment. He goes on to explain the importance of controlling the moisture level in these devices and how it can affect the drug delivery performance of the formulation."

[ONdrugDelivery @ONdrugDelivery]

Published online: "HOW CUTTING EDGE IN SILICO APPROACHES CAN REDUCE TIME AND RISK IN DEVELOPMENT OF INHALATION DEVICES". Read the full ONdrugDelivery article 👉 https://t.co/O6muLJwkLs

"Dr Peter Harley, Mariam Al-Amari and Matt Jones of Crux Product Design explore how in silico approaches can transform pulmonary and nasal drug delivery device development, illustrating through case studies – spanning low-global-warming potential propellants, assembly robustness, device-user interaction, variability and capsule piercing dynamics – how simulation-led in silico approaches can improve understanding of device performance and identify risks early, reducing development costs and accelerating the path to more reliable, innovative and patient-friendly drug-device systems."

[ONdrugDelivery @ONdrugDelivery]

Published online: "DISSOLUTION TESTING FOR ORALLY INHALED PRODUCTS: CONFRONTING THE CHALLENGES, REALISING THE POTENTIAL". Read the full ONdrugDelivery article 👉 https://t.co/gX1pJsfAux

"As dissolution testing rises up the agenda for orally inhaled product developers, Jamie Clayton of Copley Scientific explores drivers behind its adoption and key considerations for developing a robust and relevant method."

[ONdrugDelivery @ONdrugDelivery]

Published online: "STRESS-TESTING INHALED MEDICINE SO PATIENTS CAN BREATHE EASIER". Read the full ONdrugDelivery article 👉 https://t.co/vtuVcxCg3b

"Dr Yannick Baschung of Solvias discusses the benefits and challenges of orally inhaled and nasal drug products and examines how drug developers can stress test their products to improve regulatory success and patient safety, as well as how partnering with an expert CRO can provide an efficient way of performing critical characterisation testing."

[ONdrugDelivery @ONdrugDelivery]

Published online: "RESPIRATORY MUCOSAL VACCINATION: HOW COULD WE DELIVER ANOTHER GLOBAL VACCINATION RESPONSE WITH CURRENT DEVICE TECHNOLOGIES?". Read the full ONdrugDelivery article 👉 https://t.co/uGX8hP5gGR

"Mark Parry of Intertek discusses the potential needs and opportunities for respiratory drug delivery devices in the context of a hypothetical global vaccination strategy, considering a variety of factors and how different respiratory device approaches could perform."

[ONdrugDelivery @ONdrugDelivery]

Published online: "Interview: Aptar Pharma Expansion With New R&D Center". Read the full ONdrugDelivery article 👉 https://t.co/SR7296EVV0

"In this interview, Christophe Pierre introduces Aptar Pharma’s new R&D Center in France, and outlines how the new facility will assist the development of smarter, more integrated drug delivery solutions, facilitating progression from concept to full-scale industrialisation across multiple therapeutic fields."

[ONdrugDelivery @ONdrugDelivery]

Published online: "EXPANDING OPPORTUNITIES FOR INHALED DRUG DELIVERY". Read the full ONdrugDelivery article 👉 https://t.co/her1zHuzO5

"Dr Gunilla Petersson of Nanoform considers the challenges associated with efficiently delivering drugs to the lungs and the potential of nanoparticle-based formulations to achieve high lung deposition of small molecules and biologics, using gentle particle processing techniques that enable the delivery of sensitive drugs."

[ONdrugDelivery @ONdrugDelivery]

Published online: "INHALED OLIGONUCLEOTIDES – THE FUTURE FOR RESPIRATORY DISEASES". Read the full ONdrugDelivery article 👉 https://t.co/6aNHIn3Gsf

"Dr Philippe Rogueda of Merxin Ltd discusses the therapeutic potential promised by oligonucleotides and presents the case for prioritising the inhalation route as the ideal delivery mechanism for these drugs, highlighting how direct delivery to the lungs via devices such as dry power inhalers or soft mist inhalers can maximise the therapeutic efficacy and minimise the side effects of these exciting drugs."

[ONdrugDelivery @ONdrugDelivery]

Published online: "CHARTING THE COURSE FOR PULMONARY DRUG DEVELOPMENT". Read the full ONdrugDelivery article 👉 https://t.co/fUpY2x6N6h

"Catalent‘s Carolyn Berg and Dr Alan Watts examine strategy considerations that can help emerging biotech companies navigate early-stage pulmonary drug development, providing practical guidance for addressing challenges of respiratory delivery and avoiding common pitfalls that can derail development programmes."

[ONdrugDelivery @ONdrugDelivery]

Published online: "SUSTAINABILITY AS STRATEGY: HOW PHARMA IS DRIVING CLIMATE INNOVATION". Read the full ONdrugDelivery article 👉 https://t.co/i5dBCUvhq1

"Dr Sofia Sotiropoulou of Lonza Capsugel discusses the increasing emphasis that pharma companies are putting on sustainability metrics, and how they are extending this emphasis to their entire supply chains, placing expectations on design and manufacturing partners to participate in meeting sustainability targets."